SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%
新闻
CDXS
--
0.00%
--
Codexis to Participate in Two Virtual Investment Conferences
REDWOOD CITY, Calif., May 27, 2020 -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment.
GlobeNewswire · 4天前
Should Codexis Investors Prepare for Slower Growth?
Motley Fool · 05/23 00:31
H.C. Wainwright Sticks to Their Buy Rating for Codexis
Investing.com · 05/11 11:51
HC Wainwright & Co. Reiterates Buy on Codexis, Lowers Price Target to $21
HC Wainwright & Co. reiterates Codexis (NASDAQ:CDXS) with a Buy and lowers the price target from $22.5 to $21.
Benzinga · 05/11 11:18
Codexis to Present at the UBS Virtual Healthcare Conference
REDWOOD CITY, Calif., May 11, 2020 -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare.
GlobeNewswire · 05/11 11:00
Codexis, Inc. (CDXS) CEO John Nicols on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/10 20:41
Codexis(CDXS) Q1 2020 Earnings Call Transcript
Motley Fool · 05/09 06:30
Edited Transcript of CDXS earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/08 19:13
Codexis Q1 EPS $(0.090) Beats $(0.140) Estimate, Sales $14.700M Beat $13.250M Estimate
Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.090) per share which beat the analyst consensus estimate of $(0.140) by 35.71 percent. This is a 80 percent decrease over losses of $(0.050) per share from the same
Benzinga · 05/07 20:46
Codexis Reports First Quarter 2020 Financial Results
R&D revenue increased 26% to $9.6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19.
GlobeNewswire · 05/07 20:05
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.)
Benzinga · 05/07 11:42
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
GlobeNewswire · 05/06 21:05
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
GlobeNewswire · 05/05 12:00
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc.
Benzinga · 05/03 12:46
Codexis to Hold First Quarter 2020 Conference Call on May 7
REDWOOD CITY, Calif., April 30, 2020 -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results.
GlobeNewswire · 04/30 11:00
Earnings Preview: Codexis (CDXS) Q1 Earnings Expected to Decline
Zacks · 04/27 17:31
Gilead Sciences Races to Manufacture Remdesivir, but Chemistry Has Speed Limits
MotleyFool.com · 04/22 15:15
Near a 2-Year Low, Is Codexis Stock a Buy?
MotleyFool.com · 04/15 11:52
Is Codexis, Inc.'s (NASDAQ:CDXS) CEO Pay Justified?
Simply Wall St. · 04/07 13:37
Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
GlobeNewswire · 03/23 12:00